» Articles » PMID: 33720519

Widespread Overexpression from the Four DNA Hypermethylated HOX Clusters in Aggressive (IDHwt) Glioma is Associated with H3K27me3 Depletion and Alternative Promoter Usage

Overview
Journal Mol Oncol
Date 2021 Mar 15
PMID 33720519
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

In human, the 39 coding HOX genes and 18 referenced noncoding antisense transcripts are arranged in four genomic clusters named HOXA, B, C, and D. This highly conserved family belongs to the homeobox class of genes that encode transcription factors required for normal development. Therefore, HOX gene deregulation might contribute to the development of many cancer types. Here, we study HOX gene deregulation in adult glioma, a common type of primary brain tumor. We performed extensive molecular analysis of tumor samples, classified according to their isocitrate dehydrogenase (IDH1) gene mutation status, and of glioma stem cells. We found widespread expression of sense and antisense HOX transcripts only in aggressive (IDHwt) glioma samples, although the four HOX clusters displayed DNA hypermethylation. Integrative analysis of expression, DNA methylation, and histone modification signatures along the clusters revealed that HOX gene upregulation relies on canonical and alternative bivalent CpG island promoters that escape hypermethylation. H3K27me3 loss at these promoters emerges as the main cause of widespread HOX gene upregulation in IDHwt glioma cell lines and tumors. Our study provides the first comprehensive description of the epigenetic changes at HOX clusters and their contribution to the transcriptional changes observed in adult glioma. It also identified putative 'master' HOX proteins that might contribute to the tumorigenic potential of glioma stem cells.

Citing Articles

Analysis of DNA Methylation in Gliomas: Assessment of Preanalytical Variables.

Bomsztyk K, Mar D, Denisenko O, Powell S, Vishnoi M, Yin Z Lab Invest. 2024; 104(12):102160.

PMID: 39426568 PMC: 11709230. DOI: 10.1016/j.labinv.2024.102160.


Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.

Ghisai S, van Hijfte L, Vallentgoed W, Tesileanu C, de Heer I, Kros J Acta Neuropathol. 2024; 148(1):50.

PMID: 39382765 PMC: 11464554. DOI: 10.1007/s00401-024-02811-0.


HOXD12 defines an age-related aggressive subtype of oligodendroglioma.

Nuechterlein N, Cimino S, Shelbourn A, Ha V, Arora S, Rajan S Acta Neuropathol. 2024; 148(1):41.

PMID: 39259414 PMC: 11390787. DOI: 10.1007/s00401-024-02802-1.


Association of RAN and RANBP2 Gene Polymorphisms With Glioma Susceptibility in Chinese Children.

Lin Q, Chen W, Tan J, Qian S, Su H, Zhao L Cancer Rep (Hoboken). 2024; 7(7):e2136.

PMID: 39041645 PMC: 11264102. DOI: 10.1002/cnr2.2136.


Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma.

Mamatjan Y, Voisin M, Nassiri F, Moraes F, Bunda S, So J Neuro Oncol. 2023; 25(11):2028-2041.

PMID: 37474126 PMC: 10628942. DOI: 10.1093/neuonc/noad126.


References
1.
Maupetit-Mehouas S, Court F, Bourgne C, Guerci-Bresler A, Cony-Makhoul P, Johnson H . DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34 CD15 cells in early chronic-phase chronic myeloid leukemia. Mol Oncol. 2018; 12(6):814-829. PMC: 5983208. DOI: 10.1002/1878-0261.12191. View

2.
Brinkman A, Gu H, Bartels S, Zhang Y, Matarese F, Simmer F . Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res. 2012; 22(6):1128-38. PMC: 3371717. DOI: 10.1101/gr.133728.111. View

3.
Kurscheid S, Bady P, Sciuscio D, Samarzija I, Shay T, Vassallo I . Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome Biol. 2015; 16:16. PMC: 4342872. DOI: 10.1186/s13059-015-0583-7. View

4.
Lavarone E, Barbieri C, Pasini D . Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Nat Commun. 2019; 10(1):1679. PMC: 6459869. DOI: 10.1038/s41467-019-09624-w. View

5.
OConnell M, Sarkar S, Luthra G, Okugawa Y, Toiyama Y, Gajjar A . Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications. Sci Rep. 2015; 5:14983. PMC: 4597220. DOI: 10.1038/srep14983. View